WH Ireland (LON: WHI) has confirmed that current levels of proxy votes indicate that the planned sale of the wealth management operations, departure from AIM and the winding up of the company will not be passed by shareholders. The outcome will not be certain until the general meeting tomorrow. The share price jumped 212.5% to […]

UK Investor Magazine

08.10.2025

FTSE 100 powers to record highs as Lloyds gains - UK Investor Magazine

The FTSE 100 powered to record highs on Wednesday, with precious metals miners and Lloyds helping the index shake off a poor session in the US overnight. London’s leading index was trading at 9,532 at the time of writing. “After a miserable day on Wall Street yesterday, European markets opened with a spring in their […]

UK Investor Magazine

08.10.2025

FTSE 100: Three Paths the Market Could Take Next - UK Investor Magazine

by Russell Shor How to trade the FTSE 100 The FTSE 100 has had a strong 2025 so far, gaining 16% year to date. The index trades at around 18 times earnings and offers a dividend yield slightly above 3%, supported by forecasts of £80 billion in dividends and more than £39 billion in buybacks. […]

UK Investor Magazine

08.10.2025

Aptamer Group secures contract with major pharma - UK Investor Magazine

AIM-listed Aptamer Group developer announces £360,000 deal with top-tier pharmaceutical company alongside strong commercial momentum. Aptamer Group shares jumped on Wednesday after announcing a contract worth £360,000 with a top three global pharmaceutical company to develop its Optimer® binders for radiopharmaceutical applications. The fee-for-service agreement focuses on therapeutic potential whilst retaining future licensing rights for […]

home›UK Investor Magazine

UK Investor Magazine

Economy

AIM movers: WH Ireland could lose general meeting vote and Angle refines strategy - UK Investor Magazine

FTSE 100 powers to record highs as Lloyds gains - UK Investor Magazine

FTSE 100: Three Paths the Market Could Take Next - UK Investor Magazine

Aptamer Group secures contract with major pharma - UK Investor Magazine

home
›
UK Investor Magazine